Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-08-29 4:00 pm Purchase | 2022-08-18 | 13G | Arcellx, Inc. ACLX | Cormorant Asset Management, LP | 2,200,000 5.020% | 2,200,000![]() (New Position) | Filing History |
| 2022-07-07 4:01 pm Purchase | 2022-06-27 | 13G | Altimmune, Inc. ALT | Cormorant Asset Management, LP | 3,000,000 6.130% | 3,000,000![]() (New Position) | Filing History |
| 2022-06-17 4:30 pm Purchase | 2021-12-31 | 13G | VectivBio Holding AG VECT | Cormorant Asset Management, LP | 2,840,389 6.160% | 2,840,389![]() (New Position) | Filing History |
| 2022-06-06 5:50 pm Purchase | 2022-06-03 | 13G | Prometheus Biosciences, Inc. RXDX | Cormorant Asset Management, LP | 2,224,847 5.680% | 376,825![]() (+20.39%) | Filing |
| 2022-02-14 3:18 pm Purchase | 2022-02-02 | 13G | GreenLight Biosciences Holdings GRNA | Cormorant Asset Management, LP | 9,479,058 7.720% | 9,479,058![]() (New Position) | Filing History |
| 2022-02-14 3:17 pm Purchase | 2021-12-31 | 13G | Tango Therapeutics, Inc. TNGX | Cormorant Asset Management, LP | 4,899,184 5.600% | 4,899,184![]() (New Position) | Filing History |
| 2022-02-14 3:16 pm Purchase | 2021-12-31 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Cormorant Asset Management, LP | 1,381,932 9.990% | 42,301![]() (+3.16%) | Filing History |
| 2022-02-14 3:15 pm Sale | 2021-12-31 | 13G | Prometheus Biosciences, Inc. RXDX | Cormorant Asset Management, LP | 1,848,022 4.750% | -250,000![]() (-11.92%) | Filing |
| 2022-02-14 3:14 pm Sale | 2021-12-31 | 13G | Galecto, Inc. GLTO | Cormorant Asset Management, LP | 40,810 4.040% | -45,220![]() (-52.56%) | Filing History |
| 2022-02-14 3:13 pm Purchase | 2021-12-31 | 13G | Forma Therapeutics Holdings, Inc. FMTX | Cormorant Asset Management, LP | 4,639,998 9.790% | 179,998![]() (+4.04%) | Filing History |
| 2022-02-14 3:12 pm Sale | 2021-12-31 | 13G | Cabaletta Bio, Inc. CABA | Cormorant Asset Management, LP | 1,154,424 4.070% | -750,000![]() (-39.38%) | Filing History |
| 2022-02-14 3:11 pm Sale | 2021-12-31 | 13G | C4 Therapeutics, Inc. CCCC | Cormorant Asset Management, LP | 0 0.000% | -2,490,065![]() (Position Closed) | Filing History |
| 2022-02-14 3:10 pm Sale | 2021-12-31 | 13G | Aerovate Therapeutics, Inc. AVTE | Cormorant Asset Management, LP | 52,305 7.500% | -5,714![]() (-9.85%) | Filing History |
| 2022-02-14 3:10 pm Sale | 2021-12-31 | 13G | Revolution Medicines, Inc. RVMD | Cormorant Asset Management, LP | 2,431,852 3.300% | -1,243,148![]() (-33.83%) | Filing History |
| 2022-02-14 3:09 pm Sale | 2021-12-31 | 13G | Ambrx Biopharma Inc. AMAM | Cormorant Asset Management, LP | 17,266,144 7.060% | -138,558![]() (-0.80%) | Filing History |
| 2022-02-14 3:08 pm Sale | 2021-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Cormorant Asset Management, LP | 3,002,200 6.460% | -191,774![]() (-6.00%) | Filing History |
| 2022-02-14 3:08 pm Purchase | 2021-12-31 | 13G | Constellation Pharmaceuticals, Inc. CNST | Cormorant Asset Management, LP | 5,440,451 9.770% | 325,607![]() (+6.37%) | Filing History |
| 2022-02-14 3:07 pm Sale | 2021-12-31 | 13G | BioAtla, Inc. BCAB | Cormorant Asset Management, LP | 2,038,215 5.770% | -253,845![]() (-11.07%) | Filing History |
| 2022-02-14 3:06 pm Sale | 2021-12-31 | 13G | Avidity Biosciences, Inc. RNA | Cormorant Asset Management, LP | 2,012,115 4.290% | -452,432![]() (-18.36%) | Filing History |
| 2022-02-14 3:05 pm Sale | 2021-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Cormorant Asset Management, LP | 1,679,442 2.020% | -4,731,913![]() (-73.81%) | Filing History |

